498 related articles for article (PubMed ID: 15015586)
1. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis.
Yang XH; Sladek TL; Liu X; Butler BR; Froelich CJ; Thor AD
Cancer Res; 2001 Jan; 61(1):348-54. PubMed ID: 11196185
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis.
Chen JS; Konopleva M; Andreeff M; Multani AS; Pathak S; Mehta K
J Cell Physiol; 2004 Aug; 200(2):223-34. PubMed ID: 15174092
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of apoptosis induced by SIRT1 deacetylase inhibitors in human breast cancer MCF-7 drug-resistant cells].
Li Y; Xu R; Zhang XM; Li DD; He QY
Yao Xue Xue Bao; 2008 Oct; 43(10):1003-10. PubMed ID: 19127863
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
9. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
10. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
11. Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.
Uchida Y; Itoh M; Taguchi Y; Yamaoka S; Umehara H; Ichikawa S; Hirabayashi Y; Holleran WM; Okazaki T
Cancer Res; 2004 Sep; 64(17):6271-9. PubMed ID: 15342415
[TBL] [Abstract][Full Text] [Related]
12. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.
Mizutani H; Tada-Oikawa S; Hiraku Y; Kojima M; Kawanishi S
Life Sci; 2005 Feb; 76(13):1439-53. PubMed ID: 15680309
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
15. Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death.
Lambert JC; Wang GW; Kang YJ
Toxicol Appl Pharmacol; 2001 Aug; 175(1):89-93. PubMed ID: 11509031
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-beta production.
Chorna I; Bilyy R; Datsyuk L; Stoika R
Exp Oncol; 2004 Jun; 26(2):111-7. PubMed ID: 15273662
[TBL] [Abstract][Full Text] [Related]
17. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cells.
Klostergaard J; Leroux ME; Auzenne E; Khodadadian M; Spohn W; Wu JY; Donato NJ
J Cell Biochem; 2006 May; 98(2):356-69. PubMed ID: 16440323
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and xenobiotic-metabolizing enzyme gene expression in doxorubicin-resistant MCF-7 breast cancer cells.
Akman SA; Forrest G; Chu FF; Esworthy RS; Doroshow JH
Cancer Res; 1990 Mar; 50(5):1397-402. PubMed ID: 2406012
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
